|
Market Closed -
NYSE
00:00:00 15/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.220 USD | -5.93% |
|
-9.76% | +23.33% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 179M 154M 145M 132M 248M 17.1B 252M 1.7B 665M 8.57B 672M 657M 28.46B | P/E 2026 * |
11.7x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 179M 154M 145M 132M 248M 17.1B 252M 1.7B 665M 8.57B 672M 657M 28.46B | EV / Sales 2026 * |
2.24x | EV / Sales 2027 * | 2.62x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | -5.93% | ||
| 1 week | -9.76% | ||
| Current month | -6.33% | ||
| 1 month | -4.72% | ||
| 3 months | +12.12% | ||
| 6 months | -25.25% | ||
| Current year | +23.33% |
| 1 week | 2.17 |  | 2.7 |
| 1 month | 2.17 | | 2.7 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.46 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Buy | Chief Executive Officer | 56,000 | 0.0696% | ||
| 18/11/25 | Sell | Director | 168 | 0.0002% | ||
| 03/09/25 | Free | Chief Operating Officer | 75,000 | 0.0941% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.93% | -9.76% | +50.00% | +11.00% | 179M | |
| -2.25% | -0.47% | +68.30% | +115.90% | 1,052B | |
| -0.66% | +0.43% | +47.39% | +50.54% | 627B | |
| -0.54% | +1.39% | +20.69% | +63.99% | 441B | |
| -1.99% | -3.32% | +38.71% | +35.41% | 349B | |
| -1.05% | -2.81% | +23.07% | +35.70% | 287B | |
| -2.12% | -3.67% | -1.14% | +5.37% | 241B | |
| -0.63% | +1.04% | +40.05% | +56.09% | 224B | |
| -1.19% | -3.41% | -9.57% | -52.71% | 202B | |
| +0.16% | +3.87% | +16.89% | +73.73% | 172B | |
| Average | -1.62% | +0.06% | +29.44% | +39.50% | 359.54B | |
| Weighted average by Cap. | -1.36% | +0.31% | +39.09% | +61.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.8M 68.92M 64.76M 58.9M 111M 7.63B 113M 759M 297M 3.82B 300M 293M 12.7B | 68.19M 58.9M 55.35M 50.34M 94.63M 6.52B 96.2M 649M 254M 3.27B 256M 250M 10.85B |
| Net income | 15.38M 13.28M 12.48M 11.35M 21.34M 1.47B 21.69M 146M 57.17M 736M 57.73M 56.47M 2.45B | 10.01M 8.65M 8.13M 7.39M 13.9M 957M 14.12M 95.22M 37.23M 479M 37.59M 36.78M 1.59B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | $2.220 | -5.93% | 995,919 |
| 13/08/26 | $2.360 | -9.92% | 2,001,846 |
| 12/08/26 | $2.620 | +7.82% | 2,012,469 |
| 11/08/26 | $2.430 | -2.02% | 373,852 |
| 10/08/26 | $2.480 | +0.81% | 773,425 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
